The collaboration with @Biofortis_Fr will create an innovative supply chain in which in vitro and in vivo data will be merged to provide a unique insights on the functionality of new actives in the food and pharma market #SHIMEflanders.bio/en/news/biofort…
ProDigest (@Pro_SHIME) uses a technology called SHIME® which recreates the physiology and microbiology of the entire gastrointestinal tract to assess the mechanism of action of components such as prebiotics, probiotics or drugs.
#pharma | #microbiomemicrobiomepost.com/prodigest…
An in vitro model to test #IBD before the clinical trials 🔬 Dr Marzorati from @Pro_SHIME introduces us a technology that allows to emulate the intestine: SHIME® 👇 ow.ly/SdV150xsH7R
Nice collaboration with IPSEN Consumer HealthCare and interesting research showing that L. rhamnosus GG and S. boulardii exert additive and synergistic antipathogenic activities in vitro against ETEC #SHIME_platform @IpsenGroup #Ipsen_Sponsored_studywageningenacademic.com/doi/1…
Proud to announce that for the fifth year in a row, we have been nominated among the 50 fastest growing companies in Belgium #SHIME#GreatTeam @Fast50BE @DeloitteBelgium
Our latest preclinical in vitro research with the BabySHIME® suggests that 2’-FL may help regulate gut microbial activity and composition in older formula-fed infants – helping to support gut health. authors.elsevier.com/sd/arti…
Aurelien Baudot @Pro_SHIME explores the challenges of in vivo studies in translational #Microbiome research and the introduction of SHIME, a novel in vitro gut simulation that can be used to test the efficacy of LBPs #MicrobiomeMVNT
Do not miss the interview with our CEO in the last issue of Teknoscienze (TKS Publisher). Great articles with relevance for the probiotic industry. #SHIMEteknoscienze.com/tks_issue/v…
Do not miss the roundtable #20 @Probiota (today at 12:40) with our CEO Massimo Marzorati to discuss about the ileal microbiome, gut simulation and #SHIME